Exploring the Mechanism of Chuanxiong Rhizoma against Thrombosis Based on Network Pharmacology, Molecular Docking and Experimental Verification.

He, Shasha; He, Xuhua; Pan, Shujuan; Jiang, Wenwen

He, Shasha; He, Xuhua; Pan, Shujuan; Jiang, Wenwen.

Afiliação

He S; School of Pharmacy, Guizhou University, Guiyang 550025, China.
He X; School of Pharmacy, Guizhou University, Guiyang 550025, China.
Pan S; School of Pharmacy, Guizhou University, Guiyang 550025, China.
Jiang W; Engineering Research Center of the Utilization for Characteristic Bio-Pharmaceutical Resources in Southwest, Ministry of Education, Guizhou University, Guiyang 550025, China.

Molecules ; 28(18)2023 Sep 19.

Article em En | MEDLINE | ID: mdl-37764479

Assuntos

Farmacologia em Rede; Trombose; Humanos; Simulação de Acoplamento Molecular; Fosfatidilinositol 3-Quinases; Trombose/tratamento farmacológico; Coagulação Sanguínea

Palavras-chave

Chuanxiong rhizoma; PI3K/Akt/NF-κB signaling pathway; anti-thrombosis; ligustilide; network pharmacology; tissue factor

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Trombose / Farmacologia em Rede Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google